{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T04:23:07Z","timestamp":1773289387318,"version":"3.50.1"},"reference-count":38,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2011,2,15]],"date-time":"2011-02-15T00:00:00Z","timestamp":1297728000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0017106","type":"journal-article","created":{"date-parts":[[2011,2,16]],"date-time":"2011-02-16T00:21:35Z","timestamp":1297815695000},"page":"e17106","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":26,"title":["CCR3 and Choroidal Neovascularization"],"prefix":"10.1371","volume":"6","author":[{"given":"Yiwen","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deqiang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingyu","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2011,2,15]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S0161-6420(92)31871-8","article-title":"Prevalence of age-related maculopathy. The Beaver Dam Eye Study.","volume":"99","author":"R Klein","year":"1992","journal-title":"Ophthalmology"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1210\/edrv.18.1.0287","article-title":"The biology of vascular endothelial growth factor.","volume":"18","author":"N Ferrara","year":"1997","journal-title":"Endocr Rev"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.preteyeres.2003.08.001","article-title":"Retinal and choroidal angiogenesis: pathophysiology and strategies for inhibition.","volume":"22","author":"A Das","year":"2003","journal-title":"Prog Retin Eye Res"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.preteyeres.2008.05.002","article-title":"The role of vascular endothelial growth factor and other endogenous interplayers in age-related macular degeneration.","volume":"27","author":"S Grisanti","year":"2008","journal-title":"Prog Retin Eye Res"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.preteyeres.2008.05.001","article-title":"Vascular endothelial growth factor in eye disease.","volume":"27","author":"JS Penn","year":"2008","journal-title":"Prog Retin Eye Res"},{"key":"ref6","first-page":"3158","article-title":"VEGF is major stimulator in model of choroidal neovascularization.","volume":"41","author":"N Kwak","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/jcp.10246","article-title":"VEGF-TRAP(R1R2) suppresses choroidal neovascularization and VEGF-induced breakdown of the blood-retinal barrier.","volume":"195","author":"Y Saishin","year":"2003","journal-title":"J Cell Physiol"},{"key":"ref8","article-title":"A subretinal matrigel rat choroidal neovascularization (CNV) model and inhibition of CNV and associated inflammation and fibrosis by VEGF Trap.","author":"J Cao","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.ophtha.2005.01.043","article-title":"Maximum tolerated dose of a humanized anti-vascular endothelial growth factor antibody fragment for treating neovascular age-related macular degeneration.","volume":"112","author":"PJ Rosenfeld","year":"2005","journal-title":"Ophthalmology"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa054481","article-title":"Ranibizumab for neovascular age-related macular degeneration.","volume":"355","author":"PJ Rosenfeld","year":"2006","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1056\/NEJMoa062655","article-title":"Ranibizumab versus verteporfin for neovascular age-related macular degeneration.","volume":"355","author":"DM Brown","year":"2006","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/IIO.0b013e31802bd873","article-title":"Antiangiogenic therapy in neovascular age-related macular degeneration.","volume":"47","author":"RC Lin","year":"2007","journal-title":"Int Ophthalmol Clin"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2165\/00063030-200721040-00005","article-title":"Emerging therapies for the treatment of neovascular age-related macular degeneration and diabetic macular edema.","volume":"21","author":"MV Emerson","year":"2007","journal-title":"BioDrugs"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.2165\/00003495-200868080-00002","article-title":"Neovascular age-related macular degeneration: potential therapies.","volume":"68","author":"AV Chappelow","year":"2008","journal-title":"Drugs"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1006\/pupt.2001.0281","article-title":"Chemokine receptors in airway disease: which receptors to target?","volume":"14","author":"C Owen","year":"2001","journal-title":"Pulm Pharmacol Ther"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jaci.2006.06.010","article-title":"Chemokines and their receptors in allergic disease.","volume":"118","author":"JE Pease","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/med.20181","article-title":"Small molecule antagonists for chemokine CCR3 receptors.","volume":"30","author":"LI Willems","year":"2010","journal-title":"Med Res Rev"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1146\/annurev.immunol.22.012703.104716","article-title":"Asthma: mechanisms of disease persistence and progression.","volume":"22","author":"L Cohn","year":"2004","journal-title":"Annu Rev Immunol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"7571","DOI":"10.4049\/jimmunol.166.12.7571","article-title":"Eotaxin (CCL11) induces in vivo angiogenic responses by human CCR3+ endothelial cells.","volume":"166","author":"R Salcedo","year":"2001","journal-title":"J Immunol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nature08151","article-title":"CCR3 is a target for age-related macular degeneration diagnosis and therapy.","volume":"460","author":"A Takeda","year":"2009","journal-title":"Nature"},{"key":"ref21","first-page":"964","article-title":"Systemic rapamycin inhibits retinal and choroidal neovascularization in mice.","volume":"10","author":"NS Dejneka","year":"2004","journal-title":"Mol Vis"},{"key":"ref22","first-page":"873","article-title":"Translocation of the retinal pigment epithelium and formation of sub-retinal pigment epithelium deposit induced by subretinal deposit.","volume":"13","author":"L Zhao","year":"2007","journal-title":"Mol Vis"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nm0603-669","article-title":"The biology of VEGF and its receptors.","volume":"9","author":"N Ferrara","year":"2003","journal-title":"Nat Med"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10456-008-9099-z","article-title":"Vascular permeability, vascular hyperpermeability and angiogenesis.","volume":"11","author":"JA Nagy","year":"2008","journal-title":"Angiogenesis"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1113\/jphysiol.1952.sp004789","article-title":"Vascular reactions to histamine, histamine-liberator and leukotaxine in the skin of guinea-pigs.","volume":"118","author":"AA Miles","year":"1952","journal-title":"J Physiol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.exer.2005.11.014","article-title":"A new model of experimental subretinal neovascularization in the rabbit.","volume":"83","author":"G Qiu","year":"2006","journal-title":"Exp Eye Res"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"721","DOI":"10.7164\/antibiotics.28.721","article-title":"Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle.","volume":"28","author":"C Vezina","year":"1975","journal-title":"J Antibiot (Tokyo)"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/0165-6147(91)90555-7","article-title":"FK506 and rapamycin: novel pharmacological probes of the immune response.","volume":"12","author":"JY Chang","year":"1991","journal-title":"Trends Pharmacol Sci"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1139\/y77-007","article-title":"Inhibition of the immune response by rapamycin, a new antifungal antibiotic.","volume":"55","author":"RR Martel","year":"1977","journal-title":"Can J Physiol Pharmacol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/BF01024778","article-title":"Complete amino acid sequence of the FK506 and rapamycin binding protein, FKBP, isolated from calf thymus.","volume":"10","author":"WS Lane","year":"1991","journal-title":"J Protein Chem"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/sj.clpt.6100317","article-title":"Rapamycin: something old, something new, sometimes borrowed and now renewed.","volume":"82","author":"CM Hartford","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/(SICI)1097-4652(199902)178:2<235::AID-JCP13>3.0.CO;2-S","article-title":"MAP kinases, phosphatidylinositol 3-kinase, and p70 S6 kinase mediate the mitogenic response of human endothelial cells to vascular endothelial growth factor.","volume":"178","author":"Y Yu","year":"1999","journal-title":"J Cell Physiol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/1097-4644(20010601)81:3<430::AID-JCB1056>3.0.CO;2-G","article-title":"Involvement of p70 S6 kinase in bone morphogenetic protein signaling: vascular endothelial growth factor synthesis by bone morphogenetic protein-4 in osteoblasts.","volume":"81","author":"O Kozawa","year":"2001","journal-title":"J Cell Biochem"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"17686","DOI":"10.1074\/jbc.M009128200","article-title":"Identification of tyrosine residues in vascular endothelial growth factor receptor-2\/FLK-1 involved in activation of phosphatidylinositol 3-kinase and cell proliferation.","volume":"276","author":"V Dayanir","year":"2001","journal-title":"J Biol Chem"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nm0202-128","article-title":"Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor.","volume":"8","author":"M Guba","year":"2002","journal-title":"Nat Med"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.1128\/MCB.21.12.3995-4004.2001","article-title":"HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression.","volume":"21","author":"E Laughner","year":"2001","journal-title":"Mol Cell Biol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/jmcb\/mjp011","article-title":"CCR3: Shedding new light on a dark problem?","volume":"1","author":"AB Mason","year":"2009","journal-title":"J Mol Cell Biol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/nprot.2008.172","article-title":"Direct labeling and visualization of blood vessels with lipophilic carbocyanine dye DiI.","volume":"3","author":"Y Li","year":"2008","journal-title":"Nat Protoc"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0017106","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T01:26:16Z","timestamp":1637285176000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0017106"}},"subtitle":[],"editor":[{"given":"David","family":"Milstone","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2011,2,15]]},"references-count":38,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2011,2,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0017106","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2,15]]}}}